Catalyst Wire Dossier Catalyst Wire Dossier

Brimonidine tartrate/timolol maleate ophthalmic solution

brimonidine tartrate and timolol maleate · Leading Pharma, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Brimonidine tartrate/timolol maleate ophthalmic solution, covering 2022-04-20 to 2025-02-25. Get the full timeline:

Most recent: FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Leading Pharma, LLC)

See pricing